Safe Orthopaedics announces first SORA-assisted surgeries and
production of two new units
Safe
Orthopaedics announces first SORA-assisted surgeries and production
of two new units
- First surgeries performed with the SORA surgical
assistant in the first French evaluation center and the support of
Doctor Pierre Vallèse
- Two new SORA units produced for installation in France
and Germany
- Interview with Dr. Pierre Vallèse, orthopaedic and
trauma surgeon at the Convert Clinic in
Bourg-en-Bresse
|
|
|
|
Éragny-sur-Oise,
Fleurieux-sur-l'Arbresle, October 13, 2021 at 5:45 pm CET
- Safe Orthopaedics (FR0013467123 - ALSAF), a company specializing
in the design, manufacture and marketing of ready-to-use
technologies for back surgery, particularly safe for
emergency-treated vertebral fractures, announces the first
surgeries performed under SORA and the deployment of two other SORA
units.
SORA offers three main functions:
1) Assisted selection of implants and
instruments in the operating room: SORA eliminates the risk of
error in product selection, tracks lot numbers and informs all
relevant hospital departments of what has been implanted.
2) Virtual assistant for surgeons and medical
staff: the surgical documentation of implants and instruments
contained in SORA is accessible via the software and online
surgical assistance. SORA offers virtual assistance via the
interactive touch screen. Safe Orthopaedics experts can also be
invited virtually to answer questions before, during and after the
procedures.
3) Automated replenishment and inventory
management support: through automated ordering processes, SORA
helps reduce delivery times after each surgery, improve operations
planning, and reduce time, resources, and logistics costs for
hospitals.
As announced on January 4, 2021, during the
launch of the Virtual Operating Room Assistant, the first targeted
evaluation was launched with Dr. Vallèse, Head of Department at the
Convert Clinic in Bourg-en-Bresse. Two other SORA units are
currently being deployed in Paris and Frankfurt.
Pierre Dumouchel, Chairman and CEO of
Safe Orthopaedics, said: "In addition to the
medico-economic benefits of our Safe Orthopaedics ready-to-use
technologies, we are now deploying new digital services to improve
patient care, increase logistical efficiency in hospitals and
reduce associated costs. SORA is a strategic platform for
innovation and growth for the Safe Group. We thank Dr Vallèse and
his team at the Convert Clinic for their full involvement in the
evaluation of SORA and we look forward to manufacturing new SORA
units for deployment in new French and German centers by the end of
2021. We hope to deploy this model internationally in 2022 and
develop new clinical and digital education features”.
Dr. Pierre Vallèse, Orthopedic Surgeon, first evaluator
of the SORA Operating Assistant, gives a first progress
report:
How important is it for you to optimize
the operating time, for the medical team to have a simple and fast
solution to ensure the traceability of the implantation and a
restocking of the material within 24 hours?
"Operating time is an essential parameter of our
surgical practice. Without falling into the trap of excessive
profitability, optimizing operating time can have a beneficial
effect on the incidence of septic complications, on team efficiency
and on improving the flow of operations.The management of
implantable devices in health care institutions has become
increasingly complex over the last few years, with frequent
problems of restocking or inventory. All this generates stress
within the team with a transfer of responsibilities and can lead to
undesirable events.The SORA solution is the perfect answer to this
problem by providing real-time access to the availability of
materials on the screen. As soon as an implant is delivered by the
machine, the order form is immediately transmitted via an Internet
connection to Safeortho, which ensures rapid restocking in less
than 24 hours. By limiting the number of intermediaries between the
implanter and the manufacturer, traceability is made more reliable
and responsibilities are better assumed. Indeed, when the problem
of availability or expiration of an implant arises, it is useless
to look for a person in charge in the pharmacy or in the operating
room because only the surgeon is in the front line with his CPR. It
is therefore a good thing that the surgeon has control over the
implants while freeing himself from the administrative part.”
Do you think that virtual assistance in
the operating room by Safe can help you (or your OR
team)?
"In addition to the logistical support provided
by the SORA solution, virtual assistance is an innovative step
forward. All operating techniques can be consulted directly on the
machine screen by the staff and, in the event of a problem, a video
connection can be established with a technical advisor. This limits
the number of people in your operating room while guaranteeing the
technical assistance often desired. I have noticed a real interest
from the young IBODEs in this digital aid that they master
perfectly, with intuitive information on the tablet of very good
quality.
Do you think that the industry should
develop digital solutions to facilitate patient management, from
the first consultation to the scheduling of surgery and
post-operative follow-up?
"Yes, of course, because we need to provide our
patients with the best techniques and the best implants. The
partnership between the industry and the surgeon is essential for
the realization of quality studies. The digital tool brings an
undeniable performance in this field because it allows the
cross-referencing of clinical and conceptual data on implants. It
also allows to secure this data by referring to the RGPD
rules. The accesses are controlled and can be restricted for
each operator to avoid any drift of the system. Indeed, it is
important that each party (surgeon and industrialist) keeps its
independence and that the main actor, i.e. the patient, keeps the
full ownership of his data and prohibits any exploitation that
could be harmful to him. The SORA system will therefore have to
meet these requirements in the collection and processing of data.
This is a daring challenge, as many solutions exist today but are
still struggling to emerge due to the complexity of the regulation
in force and the coveted search for DATA.”
Would you be willing to connect SORA
during your surgeries to remotely train young surgeons in new
surgical techniques and/or the use of Safe products?
"Companionship is an important part of our
surgical training. For the past two years, the pandemic has had a
negative impact on this training and we may have to review the way
it is carried out. Giving access to live surgeries is a very
interesting option of the SORA solution. I would be happy to share
my experience but also to be able to call upon the experience of
other surgeons in my practice.”
About Safe GroupSafe Group is a
French medical technology group that brings together Safe
Orthopaedics, a pioneer in ready-to-use technologies for spine
pathologies, and Safe Medical (formerly LCI Medical), a
subcontractor of medical devices for orthopedic surgery. The group
employs approximately 150 people.
Safe Orthopaedics develops and manufactures kits
combining sterile implants and single-use instruments, available at
any time to the surgeon. These technologies are part of a minimally
invasive approach aimed at reducing the risk of contamination and
infection, for the benefit of the patient and with a positive
impact on hospitalization times and costs. Protected by 18
patent families, SteriSpineTM kits are CE marked and FDA approved.
Safe Orthopaedics is headquartered in the Paris region
(Eragny-sur-Oise (95610)) and has subsidiaries in the United
Kingdom, Germany, the United States and the Lyon region
(Fleurieux-sur-l'Arbresle).
For more information:
www.safeorthopaedics.com
Safe Medical produces implantable medical
devices and ready-to-use instruments. It has an innovation centre
and two production sites in France (Fleurieux-sur-l'Arbresle,
69210) and Tunisia, offering a wide range of industrial services:
design, industrialisation, machining, finishing and sterile
packaging. Supported by the French recovery plan in 2020, the
company invests in additive printing and will be operational in
2022 on this new technology.
For more information: www.safemedical.fr
Contacts
Safe
Orthopaedics
François-Henri Reynaud
Chief Financial and Administrative Officer
Tél. : +33 (0)1 34 21 50
00
investors@safeorthopaedics.com
Press RelationsUlysse
CommunicationPierre-Louis Germain / +33 (0)6 64 79
97 51 / plgermain@ulysse-communication.comBruno
Arabian / +33 (0)6 87 88 47 26 /
barabian@ulysse-communication.com
SAFE (EU:ALSAF)
Historical Stock Chart
Von Jun 2024 bis Jul 2024
SAFE (EU:ALSAF)
Historical Stock Chart
Von Jul 2023 bis Jul 2024